GlaxoSmithKline PLC
XBER:GS7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
XBER:GS7
|
UK |
|
M
|
MSC Industrial Direct Co Inc
F:98M
|
US |
|
Acarix AB
F:7AC
|
SE |
|
C
|
Cronos Group Inc
DUS:7CI
|
CA |
Wall St Price Targets
GS7 Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GS7 is 17.457 EUR with a low forecast of 11.991 EUR and a high forecast of 23.561 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GS7's stock price target?
Price Target
17.457
EUR
According to Wall Street analysts, the average 1-year price target for GS7 is 17.457 EUR with a low forecast of 11.991 EUR and a high forecast of 23.561 EUR.
What is the Revenue forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for GlaxoSmithKline PLC?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for GlaxoSmithKline PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for GlaxoSmithKline PLC?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for GlaxoSmithKline PLC?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 6%.
